Nature, Published online: 15 July 2026; doi:10.1038/s41586-026-10786-z

Chimeric antigen receptor (CAR) T cells for antitumour therapy ‘armoured’ with a dominant-negative TGFβ receptor II show enhanced efficacy and tolerable safety in patients with advanced hepatocellular carcinoma who have developed resistance or not responded to previous treatment.

Nature Energy, Published online: 14 July 2026; doi:10.1038/s41560-026-02119-1

Author Correction: Thin membranes with Cu-ion crosslinking for high temperature polymer electrolyte membrane fuel cells